Random

FDA

Is That New Drug Better? A Comparative Look

Tests and Testing Health Pulse FDA

Is That New Drug Better? A Comparative Look

A New Opioid Deterrent Falls Short For FDA

A New Opioid Deterrent Falls Short For FDA

Suzanne B. Robotti

5 Ideas To Make Prescription Drugs Safer

5 Ideas To Make Prescription Drugs Safer

Suzanne B. Robotti

Tianeptine Dangerous, FDA Says

Antidepressants and Anxiety Meds

Tianeptine Dangerous, FDA Says

FDA’s Black Box Warning for Xeljanz Leaves Patients, Doctors Scratching Their Heads

FDA’s Black Box Warning for Xeljanz Leaves Patients, Doctors Scratching Their Heads

FDA Commissioner Wants Doctor Education on Opioid Prescribing

FDA Commissioner Wants Doctor Education on Opioid Prescribing

Time For The FDA To Get Tough On Off-Label Drug Promotion

Time For The FDA To Get Tough On Off-Label Drug Promotion

FDA

Judge vs. FDA: Drug Safety and Effectiveness

Suzanne B. Robotti

Why The FDA Withdrew Emergency Use Status For Hydroxychloroquine

Why The FDA Withdrew Emergency Use Status For Hydroxychloroquine

woman receiving intravenous infusion

MedShadow Articles

FDA SIDE EFFECTS UPDATE: New Liver Injury Warnings for MS Drugs and Epilepsy Treatment

FDA: Breast Cancer Treatment

Quick Hits: FDA Breast Cancer Treatment & More

Scott Gottlieb’s FDA Legacy

Scott Gottlieb’s FDA Legacy

FDA Issues Warning on Kratom

Antidepressants and Anxiety Meds

FDA Issues Warning on Kratom

FDA Drug Recalls and Warnings: Illegal GLP-1 Sales and Misleading Marketing by Novo Nordisk and Eli Lilly

FDA Drug Recalls and Warnings: Illegal GLP-1 Sales and Misleading Marketing by Novo Nordisk and Eli Lilly

FDA Drug Recalls and Warnings: Compounded Semaglutide and Tirzepatide

FDA Drug Recalls and Warnings: Recalls for Compounded Semaglutide and Tirzepatide, Wegovy; Facility Warning Letters

What to Know About the Right to Try Law in 2024

What to Know About the Right to Try Law in 2024

MedShadow Articles

Choices For The Terminally Ill: FDA’S Expanded Access Program Or Right To Try Act?

Jessica DiGiacinto

FDA

Dear FDA: Do More When Nuplazid Has Issue After FDA Approval

Quick Hits: Drug Developments, FDA's Approval & More

Quick Hits: Drug Developments, FDA’s Approval & More

FDA Cracks Down on Online Sellers of Rx Opioids

FDA Cracks Down on Online Sellers of Rx Opioids

Vicodin

Vicodin is Now in the Most Restricted Category of Drugs

Suzanne B. Robotti

Load More

x

x